Ignite Creation Date:
2024-06-16 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06426953
Status:
RECRUITING
Last Update Posted:
2024-05-23
First Post:
2024-05-19
Brief Title:
Predictive Effect of TGF-β and INS-PI3K-AKT Related Proteins for POD in Diabetes Patients
Sponsor:
Xie Kangjie
Organization:
Zhejiang Cancer Hospital
Study Overview
Official Title:
Predictive Effect of TGF-β Combined With INS-PI3K-AKT Signaling Pathway Related Proteins ADNP MAP6 Pgc-1α for POD in Diabetes Patients
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To investigate the relationship between POD TGF-β and INS-PI3K-AKT signaling pathway related proteins ADNP MAP6 PGC-1α in diabetic patients
Detailed Description:
The study was a two-center prospectivesingle blind blinded to subjects and evaluatorscontrol observational clinical study Participants will collect 3 milliliters of blood from enrolled patients before surgery begins The collected blood samples were processed and stored in -80 refrigerator All samples were tested TGF-β and INS-PI3K-AKT signaling pathway related proteins ADNP MAP6 PGC-1α by ELISA
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None